novartis hit acquisition trail swiss drugmaker novartis announce euros purchase make sandoz unit world big generic drug producer novartis last month forecast record sale say buy germany hexal also acquire hexal u affiliate eon lab offer buy remain share novartis say would able make cost saving year follow acquisition novartis share rise swiss franc early trading deal see novartis sandoz business overtake israel teva pharmaceutical world big maker generic base figure newly merge producer would sale company estimate novartis say would merge number department add may job cut strong growth outlook sandoz create job expect partially compensate necessary reduction work force firm say statement generic drug chemically identical expensive brand rival producer sandoz copy brand product usually patent protection expire sell cheaply pay research development cost generic drugmakers worldwide analyst predict consolidation market call fragment however analyst initially convinced deal expensive acquisition birgit kuhlhoff sal oppenheim investment bank tell reuters find strange make acquisition exactly market suffer price pressure